The Japanese pharma is currently investigating mezagitamab’s potential in two late-stage autoimmune programmes.
Inherited platelet disorders represent a heterogeneous group of genetic conditions that affect the number, size, or function of platelets, with clinical manifestations ranging from mild mucocutaneous ...
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...
Platelets are an important part of the atherothrombotic process. They are involved in the pathways leading to atherosclerosis formation and progression and are central to the development of thrombus ...
MedPage Today on MSN
Anti-CD38 antibody safe, effective in immune thrombocytopenia
Small trial shows similar rate of adverse events to placebo ...
Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution. The latest application ...
Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...
To increase your platelet count, you can adjust your diet and vitamin regimen to include more vitamin C, folate, iron, and other essential nutrients. This is extremely helpful if you have a low ...
Hemophilia, von Willebrand disease, anemia, leukemias, or a low platelet count can cause bruising. A person should contact a doctor if they are concerned about their bruising. Bruising is one of the ...
Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results